The Impact on Patients' Lives
Applying AI to All Stages of Drug Discovery and DevelopmentA Discussion on the Human Impact of AI/ML in Cancer Research
With the exploding availability of omics data, the pharmaceutical industry has significantly increased investment in AI/ML technology to extract information to guide all aspects of R&D, from target identification, patient selection, and stratification to real-world evidence generation. When correctly applied, these investments result in not only accelerating business but also directly impacting human life. Sylvie Laquerre from Johnson & Johnson R&D (Janssen Pharmaceuticals) will discuss how AI/ML has helped her team to make a positive impact on people's lives. During this session you will learn:
- Why pharmaceutical companies are investing in data science as a top priority
- How these investments are making a significant impact on cancer research
- What this means for patients diagnosed with cancer and how this progress may shape treatment strategies